{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Abou Haidar E"],"funding":["NCI NIH HHS"],"pagination":["101556"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12419009"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["33(3)"],"pubmed_abstract":["Tuberous sclerosis complex (TSC) is a dominantly inherited disease in which most individuals are born with one defective allele encoding for either hamartin (TSC1) or tuberin (TSC2), with a somatic loss of the other allele leading to abnormal neurodevelopment and upregulation of cell growth in susceptible tissues. Ninety percent of affected individuals have brain involvement, including epilepsy, cognitive impairment, autism, and/or sleep disorders. In the stochastic, cerebral mouse model of Tsc1, loss of function of hamartin is induced in the CNS by injection of an adeno-associated virus (AAV) vector encoding Cre recombinase into the cerebral ventricles of homozygous Tsc1<sup>flox/flox</sup> mice at birth. In the brain, Tsc1 loss leads to increased proliferation of subventricular zone cell"],"journal":["Molecular therapy. Methods & clinical development"],"pubmed_title":["AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1."],"pmcid":["PMC12419009"],"funding_grant_id":["K22 CA282019"],"pubmed_authors":["Roumieh E","Geffrey AL","Chen JW","Soberman RJ","Wojtkiewicz GR","Stemmer-Rachamimov A","Breyne K","Tomeh T","Han JS","Gurevich M","Breakefield XO","Mahamdeh M","Abou Haidar E","Prabhakar S"],"additional_accession":[]},"is_claimable":false,"name":"AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1.","description":"Tuberous sclerosis complex (TSC) is a dominantly inherited disease in which most individuals are born with one defective allele encoding for either hamartin (TSC1) or tuberin (TSC2), with a somatic loss of the other allele leading to abnormal neurodevelopment and upregulation of cell growth in susceptible tissues. Ninety percent of affected individuals have brain involvement, including epilepsy, cognitive impairment, autism, and/or sleep disorders. In the stochastic, cerebral mouse model of Tsc1, loss of function of hamartin is induced in the CNS by injection of an adeno-associated virus (AAV) vector encoding Cre recombinase into the cerebral ventricles of homozygous Tsc1<sup>flox/flox</sup> mice at birth. In the brain, Tsc1 loss leads to increased proliferation of subventricular zone cell","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-05-26T11:09:22.428Z","creation":"2026-05-24T03:07:34.351Z"},"accession":"S-EPMC12419009","cross_references":{"pubmed":["40932991"],"doi":["10.1016/j.omtm.2025.101556"]}}